Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxegol for Opioid-Induced Constipation in Cardiac Surgery Patients
NCT03316859Phase 3Unknown
- Sponsor
- TriHealth
- Start
- Nov 2017
- Primary completion
- Dec 2022
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of naloxegol in opioid-induced constipation (OIC), sponsored by TriHealth. Status: unknown.
02
Drugs
naloxegol
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT03316859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03316859.